Adjuvant hormone therapy in postmenopausal patients with locally advanced breast cancer: hope and reality
The clinical efficiency of adjuvant hormone therapy has been considered in patients with operable breast cancer in international ran- domized mulricenter studies. The use of aromatase inhibitors versus tamoxifen is shown to considerably improve relapse-free survival and to reduce the risk of distant...
Saved in:
| Main Author: | V. I. Borisov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-07-01
|
| Series: | Опухоли женской репродуктивной системы |
| Subjects: | |
| Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/158 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Endocrine Therapy in Hormone-Receptor-Positive Breast Cancer: From Tumor Biology to the Rationale for Therapeutic Tunning
by: Oana Maria Burciu, et al.
Published: (2025-07-01) -
Aromatase inhibitors therapy and major osteoporotic fracture risk in postmenopausal breast cancer patients: a nationwide real-world cohort study
by: Pin-Han Liu, et al.
Published: (2025-05-01) -
Cardiovascular and metabolic effects of ovarian suppression in combination with tamoxifen or an aromatase inhibitor as adjuvant therapy for early oestrogen receptor-positive breast cancer: a systematic review
by: Ying X. Gue, et al.
Published: (2024-07-01) -
Adjuvant endocrine treatment strategies for non-metastatic breast cancer: a network meta-analysisResearch in context
by: Andri Papakonstantinou, et al.
Published: (2025-03-01) -
Cardiovascular risks associated with adjuvant endocrine therapy in women with breast cancer: a population-based cohort study
by: Iokfai Cheang, et al.
Published: (2025-07-01)